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Abstract Sperm L-acrosin activity is inhibited by suramin, a
polysulfonated naphthylurea compound with therapeutic poten-
tial as a combined antifertility agent and microbicide. A kinetic
analysis of enzyme inhibition suggests that three and four mol-
ecules of suramin bind to one molecule of ram and boar
L-acrosins respectively. Surface charge distribution models of
boar L-acrosin based on its crystal structure indicate several
positively charged exosites that represent potential ‘docking’
regions for suramin. It is hypothesised that the spatial arrange-
ment and distance between these exosites determines the ca-
pacity of L-acrosin to bind suramin.
! 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Proacrosin, the zymogen form of the serine protease L-acro-
sin (EC 3.4.21.10), is found speci¢cally within the acrosomal
vesicle of spermatozoa from ascidians to mammals [1^3]. Its
primary sequence shows signi¢cant identity to other serine
proteases such as trypsin (35%), chymotrypsin (33%), elastase
(29%) and kallikrein (27%) [1]. Proacrosin is also one of a
cohort of reproductive proteins that show a high rate of se-
quence diversi¢cation, a characteristic feature of adaptive evo-
lutionary processes that contribute to speciation [4]. In intact
spermatozoa proacrosin is complexed to several binding pro-
teins and inhibitors within the acrosomal matrix and is only
converted to L-acrosin following exocytosis of the acrosomal
vesicle. Unusually for a serine protease, it autoactivates by
internal cleavages at both the N- and C-termini to produce
a truncated two-chain molecule cross-linked by disul¢de
bridges [5]. Recently, the three-dimensional structures of
boar and ram sperm L-acrosins were determined by X-ray
crystallography and were noteworthy for the presence of pos-
itively charged ‘patches’ of basic residues close to the active
site [6]. These patches allowed close apposition of adjacent
molecules within the crystal stack via ionic bonding of
charged carbohydrate chains. From a physiological stand-
point, L-acrosin is thought to be a multifunctional protein
with putative roles during fertilisation as a secondary zona
binding molecule [7,8], for facilitating dispersal of the acroso-
mal matrix [9] and as an activator of protease activated re-
ceptor 2 (PAR2) on the oolemma following zona penetration
[10].
In previous experiments we reported that the drug suramin
inhibits both the amidase activity of L-acrosin and binding of
spermatozoa to the zona pellucida (ZP) in vitro [11]. Suramin
is a symmetrical hexasulfonated naphthylurea compound (Fig.
1) that was originally synthesised as a trypanocidal agent for
treatment of sleeping sickness in East Africa [12]. Lately, it
has found diverse applications as an anticancer drug because
of its ability to block angiogenesis, inhibit reverse transcrip-
tase and cause microaggregation of growth factors [13,14].
Although suramin binds to a variety of proteins (e.g. human
chymase [15], protein tyrosine phosphatase [16] and heparin-
ase [17]) it can also discriminate between closely related mem-
bers of the same family suggesting that the ‘docking’ sites are
very precise. Thus, it is a potent inhibitor of human elastase,
neutrophil protease 3 and cathepsin G but has little or no
e¡ect on pancreatic trypsin and chymotrypsin [18]. Binding
of suramin is principally ionic and depends on the correct
spatial alignment between sulfonate groups on the terminal
naphthalene rings and basic residues on the surface of the
target protein in a manner similar to that found for hepa-
rin^antithrombin III interactions [19]. The ratio of suramin
binding to protein is often greater than 1, suggesting the pres-
ence of several docking sites [18,20].
The inhibitory e¡ects of suramin on secondary binding of
spermatozoa to the ZP of the egg [8], together with its anti-
viral activity [21], suggest that it has potential as a combined
antifertility agent and microbicide. To further substantiate
this hypothesis, we have investigated the stoichiometry and
kinetics of binding of suramin to L-acrosin from ram and
boar spermatozoa. We show that either three or four mole-
cules of suramin bind per molecule of L-acrosin and predict
potential binding sites on the surface of the protein from
charge density models of its three-dimensional structure.
2. Materials and methods
2.1. Materials
Substrate S2288 (D-Ile-Pro-Arg-p-nitroanilide) was purchased from
Helena Laboratories (Mt. Waverly, Australia). p-Nitrophenyl pP-gua-
nidino-benzoate, methyl-umbelliferyl-guanidino-benzoate and methyl-
umbelliferone were obtained from Sigma (Sydney, Australia). Sura-
min hexasodium salt was supplied by AG Scienti¢c (San Diego, CA,
USA). L-Acrosin was puri¢ed to homogeneity from ejaculated ram
and boar spermatozoa as described previously [22]. The protein gave a
single band at V38 kDa following sodium dodecyl sulphate^polyac-
rylamide gel electrophoresis (SDS^PAGE)/Coomassie blue staining
and was judged to be s 95% pure by densitometry. The protein
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was lyophilised and stored at 320‡C. Under these conditions the
enzyme is stable for several years.
2.2. Enzyme assays and kinetic analysis
Boar L-acrosin was titrated with p-nitrophenyl pP-guanidino-ben-
zoate in 0.035 M sodium barbitone pH 8.3 at 25‡C [23]. Ram
L-acrosin was titrated with methyl-umbelliferyl-guanidino-benzoate
in 0.035 M sodium barbitone pH 8.3 at 37‡C using a Perkin Elmer
luminescence spectrometer LS50B (excitation, 365 nm; emission, 445
nm) [24].
Chromogenic assays were performed at 37‡C in 40 mM HEPES, 20
mM CaCl2, 200 mM NaCl, 0.1% polyethylene glycol (PEG) 6000,
1 mg/ml bovine serum albumin (BSA), pH 7.4 at 405 nm using a
Hewlett Packard 8452A diode array spectrophotometer. Before use
plastic 1.5 ml cuvettes were coated with a solution of 0.1 M NaHCO3,
1% casein, 0.02% sodium azide to prevent non-speci¢c adsorption of
proteins in the reaction mixtures to the cuvettes. Inhibition studies
were only performed with batches of L-acrosin for which the rate of
hydrolysis of S2288 demonstrated a linear dependence on enzyme
concentration. The S2288 concentration was determined from its
A342 using a molar absorption coe⁄cient of 8270 M31 cm31 [25].
Initial rates for the hydrolysis of S2288 by ram and boar L-acrosins
were measured using a range of S2288 and suramin concentrations. At
least six concentrations of S2288 were tested, with at least one below
the Kappm and one above the K
app
m . For each suramin concentration, the
data were ¢tted to the Michaelis^Menten equation (Eq. 1) by non-
linear regression:
v0 ¼ ½E0kcatkAkcat þ kA½A ð1Þ
where kcat is the catalytic rate constant and kA is the speci¢city con-
stant kcat/Km.
Non-linear regression was used to analyse the dependence of the
apparent kinetic parameters with inhibitor concentration. When Eqs.
2, 3 and 4 were ¢tted the value of kcat or kA was ¢xed. For ram
L-acrosin kcat = 31U 1 s31 and kA = (2.2U 0.1)U105 M31 s31 and for
boar L-acrosin kcat = 3.2 U 0.1 s31 and kA = (5.4 U 0.6)U105 M31 s31.
3. Results and discussion
3.1. Kinetic parameters of suramin binding on the activities of
ram and boar L-acrosins
For each suramin concentration we obtained apparent val-
ues of the speci¢city constant and the catalytic rate constant.
Pure competitive inhibitors a¡ect only the speci¢city constant
whereas uncompetitive inhibitors a¡ect only the catalytic rate
constant. Secondary plots of the inverse of kappA and k
app
cat
against inhibitor concentration are linear if the enzyme is
completely inhibited by one inhibitor molecule [26]. Complete
linear inhibition was not observed for the inhibition of L-acro-
sin by suramin (Fig. 1), so the data were ¢tted to equations
that describe incomplete inhibition by more than one inhibitor
molecule.
Surprisingly, the pattern of inhibition by suramin was dif-
ferent for ram and boar L-acrosins. For ram L-acrosin, no
competitive inhibition was observed. In fact, a single suramin
molecule actually increased the speci¢city of ram L-acrosin for
the substrate (Fig. 2a). The data for the activation of ram
L-acrosin by suramin were ¢tted by Eq. 2 which describes
the increase of the speci¢city constant by a single suramin
molecule [26].
1
kappA
¼ 1
kA
  1þ ½I 
Kact
1þ b ½I 
Kact
ð2Þ
where Kact is the equilibrium dissociation constant for the
activating suramin molecule and b= kappA /kA when [sura-
min] =r.
In contrast to ram L-acrosin, competitive inhibition was
observed for boar L-acrosin (Fig. 2c). Despite repeating the
data collection a number of times, the e¡ect of suramin on the
kappA for boar L-acrosin had a high degree of error within it.
However, it is clear that partial (90%) competitive inhibition
by more than one suramin molecule is occurring. The data
were ¢tted by Eq. 3, which describes cooperative inhibition by
two inhibitor molecules as shown in Scheme 1 [26].
1
kappA
¼ 1
kA
  1þ ½I 2
K2ic
1þ b½I 
2
K2ic
ð3Þ
where b= kappA /kA when [suramin] =r and K
2
ic is the dissocia-
tion constant for Scheme 1 for the competitive inhibitory sur-
amin molecules.
For both boar and ram L-acrosins, the e¡ect of suramin on
the kappcat was similar (Fig. 2b,d); partial inhibition by more
than one suramin molecule was observed. Di¡erent equations
that describe two inhibitor molecules, two inhibitor molecules
binding cooperatively and three inhibitor molecules were all
used to ¢t the data. Eq. 4 ¢tted the data best, and this de-
scribes cooperative inhibition by two inhibitor molecules as
shown in Scheme 1. The values for the parameters obtained
by ¢tting the equations are shown in Table 1.
Fig. 1. Structural formula of suramin.
Fig. 2. The e¡ect of suramin on (1/kA)app (a and c) and on
(1/kcat)app (b and d) for ram L-acrosin (a and b) and boar L-acrosin
(c and d).
Scheme 1.
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1
kappcat
¼ 1
kcat
  1þ ½I 2
K2iu
1þ b½I 
2
K2iu
ð4Þ
where b= kappcat /kcat when [suramin] =r and K2iu is the dissoci-
ation constant for Scheme 1 for the uncompetitive inhibitory
suramin molecules.
3.2. Charge density models of suramin binding sites on boar
L-acrosin
The three-dimensional structure of ram and boar L-acrosins
is known from X-ray crystallography and hence it is possible
to model the distribution of potential anion binding exosites
using GRASP computer programmes. As shown in Fig. 3, the
catalytic centre of boar L-acrosin, consisting of His70+
Asp124+Ser222, is surrounded by two major anion binding
regions represented by His47+Arg50+Arg51 and Arg250+
Lys252+Arg253. (Note: the numbering system adopted here
follows that of Baba et al. [5] for boar proacrosin which
begins with the N-terminal residue (Arg) of the light chain.
This is di¡erent to the chymotrypsin numbering system used
by Tranter et al. [6].) These residues have been shown by site-
directed mutagenesis to be important for ZP binding (and by
inference suramin binding) whereas an adjacent area contain-
ing three lysines (Lys75+Lys76+Lys77) does not appear to be
crucial, possibly due to the position of the latter in a ‘pocket’
formed by projecting surface loops [27]. Rotation of the pro-
tein about the Y-axis reveals several additional exosites that, if
unhindered by projecting carbohydrate chains from Asn3 and
Asn192, would also constitute potential anion binding re-
gions. Relevant to these predictions is the three-dimensional
structure of suramin itself. It is thought that sulfonate groups
on the terminal naphthalene rings (Fig. 1) are the main sites
for non-covalent interaction with proteins that, together with
its overall symmetry, enables suramin to cross-link adjacent
molecules and form intramolecular bridges. Although suramin
is £exible and can rotate around several of the internal aro-
matic rings [20], in a non-hydrated low-energy state the calcu-
lated ‘span’ between terminal sulfonate groups is in the region
of 25^30 AX . This approximates to the distance between several
of the charged exosites on the surface of L-acrosin making it
theoretically possible for several molecules of suramin to bind
to one molecule of protein.
3.3. Stoichiometry of suramin binding and relationship to
enzyme inhibition
Despite the similarity in sequence and structure of boar and
ram sperm L-acrosins, there was a clear di¡erence in the e¡ect
of suramin on their kA values. Whereas boar L-acrosin was
competitively inhibited by two molecules of suramin, ram
L-acrosin showed an increase in speci¢city for the substrate
caused by binding of a single suramin molecule. For this to
occur, suramin must be binding to a region other than the
active site and as a consequence induces a conformational
change. This same mechanism may also be happening for
boar L-acrosin, where the ¢rst suramin molecule increases
the a⁄nity for the second suramin molecule resulting in co-
operative inhibition. It has been argued previously that sur-
amin binding to proteins is unlikely to induce a conforma-
tional change [28]. However, the activation of ram L-acrosin
clearly indicates that this is possible.
The suramin molecule that acts as a competitive inhibitor
for boar L-acrosin presumably binds to a positively charged
region near to the active site. Most of the charged residues are
conserved between ram and boar L-acrosin, but Arg212 in
boar L-acrosin is changed to a Glu in ram. It is possible,
therefore, that this residue is important in binding one of
the suramin molecules. Interestingly, human L-acrosin has a
Val in this position which makes it di⁄cult to predict whether
suramin would act as a competitive inhibitor of the human
protein or not, as this is a single charge di¡erence from the
boar L-acrosin, not a double charge di¡erence as is the case
for ram L-acrosin.
Despite the small increase in speci¢city constant of ram
L-acrosin in the presence of suramin, the overall e¡ect was
inhibition. This inhibition was not complete, although it was
consistently s 90% (see b values in Table 1). The failure to
achieve complete inhibition may be due to the substrate S2288
being a relatively small molecule. It is often the case that when
Table 1
Kinetic parameters of inhibition of activity of ram and boar L-acro-
sins by suramin
E¡ect on kappA E¡ect on k
app
cat
Ram L-acrosin Kact = 10U 3 WM Kiu = 17.3U 0.2 WM
b=1.33U 0.03 b=0.0335U 0.0004
Boar L-acrosin Kic = 22U2 WM Kiu = 27U 1 WM
b=0.086U 0.006 b=0.070U 0.003
Kact is the equilibrium dissociation constant for the activating sura-
min molecule. K2iu and K
2
ic are the equilibrium dissociation constants
for Scheme 1 for the uncompetitive and competitive inhibitory sura-
min molecules, respectively. b is the fraction of either kA or kcat
that exists at in¢nite suramin concentration.
Fig. 3. Charge density model of boar L-acrosin illustrating the dis-
tribution of basic (coloured blue) and acidic (coloured red) residues
on the surface of the protein. The relative positions of individual
residues referred to in the text are shown numbered in yellow. The
model is rotated counterclockwise in 90‡ steps about the Y-axis
(1^4) to demonstrate the presence of potential docking sites for sur-
amin.
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only partial inhibition is observed with small substrates, com-
plete inhibition occurs with large protein substrates [18].
In considering the number of suramin molecules bound to
L-acrosin it is necessary to compare the Kact and Kiu values for
ram L-acrosin (Table 1). The uncompetitive inhibition was
¢tted by an equation that describes cooperative inhibition
by two molecules, which means that the second molecule
binds to L-acrosin with higher a⁄nity than the ¢rst molecule.
Because the Kiu value obtained is signi¢cantly larger than the
Kact value, and only one molecule is involved in increasing
speci¢city, then the activating suramin molecule must be dif-
ferent from the two uncompetitive inhibitor suramin mole-
cules, making a total of three suramin molecules binding to
ram L-acrosin. By analogy, for boar L-acrosin the ¢rst com-
petitive inhibitor molecule of suramin would di¡er from the
two uncompetitive suramin molecules. The second competitive
inhibitor suramin molecule only binds to boar L-acrosin and
so must be di¡erent from the other three. Hence, four suramin
molecules bind to boar L-acrosin and three to ram L-acrosin.
It is not possible at present to predict precisely where the
bound suramin molecules might lie, partly because of the un-
certainties in modelling suramin due to its inherent £exibility
and partly because of induced conformations brought about
by binding of the ¢rst suramin molecule. Only by co-crystal-
lising suramin with L-acrosin will it be possible to determine
the precise binding sites.
In light of the above results, it may be speculated that
suramin will interact with human L-acrosin in a similar man-
ner and in so doing interfere with secondary sperm binding to
the ZP [8]. Although this remains to be demonstrated, the
possibility exists that safe mimetics of suramin have potential
as antifertility agents.
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